Objective: The objective of this study was to report our experience on the use of flow diverting stents placed within the posterior inferior cerebellar artery (PICA) as a treatment option for aneurysms of the PICA. Methods: Three patients with aneurysms of the PICA, both ruptured and unruptured, underwent treatment of their aneurysms with placement of a single flow diverter in the PICA across the neck of the aneurysm. Adjunctive techniques such as coiling were not used. We present the angiographic and clinical follow-up data. Results: The procedure was a technical success in all cases and there were no intraoperative complications. Follow-up data were available for two patients and this showed complete occlusion of the aneurysm with the PICA remaining patent. There was no evidence, either clinical or radiological, of medullary or pontine infarction. One patient died during the follow-up period from an unrelated medical illness (community acquired pneumonia). Conclusion: Flow diverters can be successfully placed within the PICA to treat both ruptured and unruptured aneurysms, and they represent an alternative treatment option to endovascular coiling or microscopic neurosurgery.
Introduction
Aneurysms of the posterior inferior cerebellar artery (PICA) are rare lesions and they account for only 0.5-3% of all intracranial aneurysms. [1] [2] [3] Approximately 70% of the aneurysms arise at, or close to, the origin of the PICA from the vertebral artery with approximately 30% of aneurysms arising from the distal PICA. 4, 5 Although the majority of aneurysms are saccular, both fusiform and dissecting aneurysms have been reported in the literature. 6 The endovascular treatment of PICA aneurysms includes coiling, with or without stent or balloon assistance, and parent artery occlusion (PAO) [7] [8] [9] with neurosurgical clipping, aneurysm wrapping, PAO and bypass representing alternative surgical treatment options. From a surgical point of view, the proximity of nearby structures such as the brainstem, lower cranial nerves and limited working space can make treatment of these aneurysms technically challenging. On the other hand, the small caliber of the PICA and the configuration of the aneurysms may make obtaining a safe and stable microcatheter position difficult and, unlike aneurysms elsewhere in the brain, the surgical treatment of these lesions has generally remained the default treatment option. The treatment of these lesions is complicated further if they present with subarachnoid haemorrhage (SAH), as there is a need for expedient treatment since the aneurysm rebleed rate can be high. 10 Furthermore, there is a high frequency of intraventricular haemorrhage (IVH), with consequent hydrocephalus, that is thought to be due to the proximity of the PICA to the foramina of Luschka and Magendie, 11 and may result in patients with acutely ruptured PICA aneurysms presenting in a poor clinical condition with high Hunt and Hess grades. 8 All these factors and more must be considered when determining the optimal treatment option for individual patients. There is limited published literature regarding the use of flow diversion as part of the treatment profile for aneurysms of the PICA. [12] [13] [14] In this article, we present our experience on the use of flow diverting stents (FDSs) implanted in the PICA to treat aneurysms, both ruptured and unruptured, of this artery.
Methods

Patient population
We retrospectively reviewed our prospectively maintained database to identify patients, treated in our institution between February 2009 and February 2018, with aneurysms arising from the PICA and treated with FDSs. In addition, only patients in whom the FDS was placed entirely within the PICA were included in this analysis. Using these inclusion criteria, we identified the patients. For each patient, we recorded demographic data, clinical presentation, aneurysm characteristics, treatment data, immediate angiographic and clinical results, and clinical and radiological followup information.
Endovascular treatment
All treatments were performed under general anaesthesia after informed consent. In elective cases with unruptured aneurysms, the patients received dual antiplatelet therapy (aspirin 75 mg daily and clopidogrel 75 mg) started 7 days prior to the planned treatment. The effectiveness of the antiplatelet regime was tested using the VerifyNow device (Accumetrics) within 24 h of the planned procedure. In patients who demonstrated resistance to clopidogrel, prasugrel (10 mg) was used as a substitute. The post-procedural antiplatelet regimen consisted of clopidogrel/prasugrel continued for 6 months following treatment and aspirin continued for life.
Antiplatelet treatment in cases of acute SAH consisted of a weight-adjusted bolus dose of intra-arterial (IA) tirofiban given intraoperatively followed by an intravenous infusion for 12 h post-procedure. Once the patient is awake and able to swallow, a bolus oral dose of clopidogrel (450 mg) and aspirin (500 mg) is administered followed by 75 mg of clopidogrel and 100 mg aspirin daily. Antiplatelet function testing is performed 48-72 h after the tirofiban infusion is complete. In patients who demonstrated resistance to clopidogrel, prasugrel (10 mg) is used as a substitute. Dual antiplatelet therapy is continued for 6 months followed by aspirin for life. If an external ventricular drain is required or thought to become necessary, it is inserted prior to the procedure and/or antiplatelet medication.
All procedures were performed via the right common femoral route using a 6Fr access system with a tri-axial as standard. As standard, a 6Fr Cook Shuttle (Cook Medical, Bloomington, Indiana, USA) was tracked into the common carotid artery with either a Navien 6Fr (Medtronic, Irvine, California, USA) or a FargoMax 6Fr (Balt Extrusion, Montmercy, France) used as the intermediate catheter. All procedures were performed under heparin anticoagulation with a 5000 IU bolus dose at the start of the procedure and subsequent 1000 IU bolus doses every hour, to maintain the activated clotting time between 2-2.5 times the baseline.
Three different types of flow diverter were used, but in all cases only a single device was implanted. A p48 (phenox GmbH, Bochum, Germany) was used in one case, a pipeline embolisation device (PED) (Medtronic, Galway, Ireland) was used in another case, and the flow redirection endoluminal device junior (FRED Jnr). (Microvention, Tustin, California, USA) in another.
Procedural assessment and follow-up
Patency and flow characteristics within the PICA were assessed angiographically immediately after placement of the FDS and during follow-up. Procedural follow-up was performed initially at 3-6 months, again at 9-12 months and then once per year until aneurysm occlusion. Standard angiographic projections were used to assess the patency of the vessels and the aneurysms, in addition to angiographic projections that repeated those used during the treatment. Aneurysm occlusion was graded using the Raymond-Roy classification.
Neurological examinations were performed to evaluate for potential ischaemic or haemorrhagic complications in the post-operative period (<24 h postprocedure) and at each subsequent follow-up.
Institutional review board approval for this study was granted.
Results
We identified three patients (two females) with aneurysms located on the PICA and treated with an FDS deployed in the PICA. The average age of the patients was 53 AE 24.8 years (range 33-81). In one case, the patient presented with an acute localized SAH and in another case the aneurysm was found incidental to SAH caused by an AcomA aneurysm. The last aneurysm was found incidentally during investigation for a persistent headache. All three aneurysms were thought to be dissecting in nature. The mean average dome width was 3.27 AE 2.57 mm, dome height was 3.43 AE 3.35 mm and neck width 2.53 AE 1.5 mm. A single FDS was used in each case. A p48 (phenox GmbH, Bochum, Germany) was used in one case, a PED (Medtronic, Galway, Ireland) was used in another case, and the FRED Jnr. (Microvention, Tustin, California, USA) in another. In all cases, a 2.5 mm device was used, and the choice of device was based on operator preference and availability. There were no intraoperative complications during the procedures and contrast stagnation was seen at the end of each operation. Followup imaging is available for two patients with complete aneurysm exclusion seen in both cases. In the patient that presented with acute SAH secondary to the PICA aneurysm there was no evidence of repeat rupture. The results are summarized in Table 1 .
Individual case histories
Case 1
A 46-year-old female patient with a strong family history of intracranial aneurysms and SAH was undergoing investigation for a persistent headache. A computed tomography (CT) scan and CT angiogram of the brain revealed a small, wide necked, presumed dissecting, aneurysm of the PICA on the right (Figure 1 (a) to (c)). After discussion with the patient, the decision was taken to treat the aneurysm, although there was no evidence of SAH. After dual antiplatelet antiaggregation, a single p48 (phenox GmbH, Bochum, Germany) FDS was placed in the PICA (Figure 1 demonstrated a tiny irregularity close to the origin of the PICA on the right and this was thought to be due to a dissection. The aneurysm measured approximately 1 mm in dome width and, after multidisciplinary team discussion, flow diversion was felt to the optimal treatment option. After platelet inhibition with a weightadjusted dose of tirofiban, a single PED (2.5 Â 10 mm) was deployed without complication. Dual antiplatelet agents were commenced post-operatively. The patient was discharged with an mRS of 0 and, on follow-up angiography at 3 months, there was a miniscule aneurysm remnant (Figure 3 (a) and (b)), which had completely resolved on the 7-month angiogram (Figure 3(c) to (e)). We performed follow-up at 2 years. There was no clinical or radiological evidence of medullary infarction ( Figure 4 ) and the mRS was 0.
Case 3
An 81-year-old female patient presented with acute SAH ( Figure 5 (a)) secondary to a ruptured peri-callosal aneurysm ( Figure 5(b) ). Angiography revealed multiple aneurysms including along the PICA/anterior inferior cerebellar artery (AICA)-PICA ( Figure 5(c) ). After coiling of the peri-callosal aneurysm, the patient made a good recovery and was scheduled for treatment of the PICA aneurysms. Under dual antiplatelet antiaggregation, a FRED Jnr. An FDS was inserted into the PICA across the neck of the proximal PICA aneurysm ( Figure 5(d) and (e)). There were no intraoperative complications and at last clinical follow-up the mRS was 0. The patient died several weeks following the operation from an unrelated medical condition (community acquired pneumonia).
Discussion
Aneurysms of the PICA, although relatively uncommon, can represent a challenge for endovascular treatment and many regard these aneurysms as being more suitable for neurosurgical treatment. Aneurysms of the PICA have been previously classified based on their surgical anatomy and the surgical approach required for their treatment. 15 More recently, Srinivasan et al. 13 proposed a classification system tailored for the endovascular treatment of PICA aneurysms. They proposed that the aneurysms are initially classified as either saccular (type 1) or fusiform (type 2), and subsequently on their location:
. Type 1 a: saccular aneurysms arising from the vertebral artery-PICA; . Type 1 b: saccular aneurysms arising more than 5 mm distal to the PICA origin; . Type 2 a: fusiform/non-saccular aneurysm involving the vertebral artery-PICA junction; . Type 2 b: fusiform/non-saccular aneurysms involving the more distal PICA but still involving the perforator region; . Type 2 c: fusiform/non-saccular aneurysms arising distal to the perforator region.
Based on this classification, the potential for treatment with flow diversion can be deduced. Type 1 a and 2 a aneurysms, with involvement of the PICA origin, will require placement of the FDS in the vertebral artery across the origin of the PICA, whereas type 1 b and 2 b can be treated by placing the flow diverter within Figure 1 . A female patient with a strong positive family history of intracranial aneurysms and subarachnoid haemorrhage (first-degree relatives) was under investigation for persistent headaches. An aneurysm of the right posterior inferior cerebellar artery was discovered. On angiography, the small, wide necked aneurysm ((a) to (c)) was thought to be secondary to a dissection. A p48 was placed in the posterior inferior cerebellar artery across the aneurysm, and a significant reduction in flow was seen in the aneurysm and the end of the procedure ((d) and (e)). At follow-up angiography there was complete occlusion of the aneurysm (f).
the PICA. The authors stress the need to carefully study the precise anatomical disposition of the PICA and the associated aneurysm, and they advise that a typical proximal landing zone for the FDS in these type 1 b and 2 b aneurysms should be approximately 5 mm. Type 2 c aneurysms, although they may still be amenable to treatment with FDSs, can also be treated by PAO. We agree with this classification and believe that, in general, aneurysms of the proximal PICA can be treated with FDSs but that PAO, either with coils or liquid embolics, should be considered the treatment of choice for aneurysms involving the distal PICA.
One of the principle concerns for the placement of an FDS into the PICA has been the small size of the artery and the coverage of important perforating branches. Recently, the problem has been solved thanks to the availability of FDSs, like the Fred Jnr. (Figure 3 ) and p48 (Figure 1) , that have been designed for small arteries between 2 and 3 mm. Typically, the PICA diameter is < 2 mm (mean 1.23, range 0-2.5 mm) 16 and in the region of 1.7 mm at its origin from the vertebral artery, with a gradual tapering to approximately 1.3-1.4 mm at its distal cortical level. 13 Along similar lines, there has been concern regarding the potential for perforator infarction, which has been seen at other sites in the intracranial circulation. 17, 18 An infarction within the territory of the PICA perforators could have serious consequences and may result in a lateral medullary syndrome (Wallenburg's syndrome); however, the development of this complication was not seen in the work of Srinivasan et al., 13 nor in the two cases of ruptured PICA aneurysms reported by Guerrero et al. 14 Similarly, none of our patients developed this condition. It is worth noting that the metal coverage of an FDS varies as a parabolic function of the ratio between the vessel and the device, with the typical oversized mismatch resulting in reduced metal coverage. 19, 20 This effect could theoretically result in reduced aneurysm occlusion due to slowed neoendothelialization. The counter point to this is that the reduced coverage across any covered side branches may prevent the occlusion of small perforators. Although numerous papers have been published looking at the effects of covered branches, 21, 22 the exact effects of covered branches, especially in different anatomical locations, are still to be determined; it seems likely that given an adequate demand and limited alternative sources, flow will remain preserved.
In the acute setting, a further difficulty is the requirement for antiplatelet medication, which is believed to expose patients to an elevated risk of bleeding-related complications if interventions such as the insertion of an external ventricular drain (EVD) are required. [23] [24] [25] [26] [27] [28] Bodily et al. 29 performed a systematic review of the literature and found a total haemorrhagic complication rate of 8% (27/339), nine cases of which were related to the EVD and 12 related to intraprocedural rupture of the aneurysm. Thromboembolic events were seen in 6% of cases. Of note over half of the EVD-related haemorrhagic events came from a single case series. 30 Kung et al. 31 performed a retrospective review of 131 patients who had EVD insertion with and without concomitant dual antiplatelet therapy in the setting of acute SAH. They found that, in those patients that required dual antiplatelet therapy, the rate of radiographic haemorrhage was 32% compared to 14.7% in those that were not on antiplatelet medication, and 8% compared to 0.9% for symptomatic haemorrhagic complications, respectively. This increased risk of EVD haemorrhage is particularly important for patients with ruptured PICA aneurysms, as patients may either present or develop hydrocephalus due to the location of the clot close to the foramina of Luschka and Magendie. Given the increased risk of haemorrhage, we insert an EVD prior to initiating antiplatelet medication, and if a permanent shunt is required we usually use the same tract and burr hole as that used for the EVD, a technique that has also been shown to be safe and effective by others. 32 Similarly, as these aneurysms are often dissecting in nature, they can be very fragile with an increased risk of intraoperative haemorrhage. In these scenarios, it may be prudent to have a balloon in the vertebral artery across the origin of the PICA in case rupture does occur. However, it is important to realize that the risk of rupture when placing an endoluminal FDS may actually be lower than that of treatment that involves accessing the aneurysms.
When considering FDS placement as a treatment for aneurysms of the PICA, it is important to consider the alternative treatment options. In a recent systematic review and meta-analysis performed by Petr et al., 33 the authors identified 29 studies with 796 PICA aneurysms. When considering all patients, the overall occlusion rates were 92.2% (95% confidence interval Figure 5 . The patient was admitted with an acute subarachnoid haemorrhage (a). Angiography revealed multiple aneurysms with a multi-lobulated peri-callosal aneurysm thought to be the source of the subarachnoid haemorrhage (b). There was dolichoectasia of the left internal carotid artery, and two further aneurysms were seen along the left posterior inferior cerebellar artery/anterior inferior cerebellar artery (AICA)-posterior inferior cerebellar artery involving the P1 and P2 segments of the vessel (c). After acute coiling of the subarachnoid haemorrhage, the patient returned for treatment of the proximal left posterior inferior cerebellar artery aneurysm with a FRED Jnr. flow diverting stent ((d) and (e)). There were no immediate complications. The patient died from an unrelated medical illness.
(CI) ¼ 86.5-96.6%). For unruptured aneurysms treated surgically, the occlusion rate was 92.9% (95% CI ¼ 79.5-100%) with recurrence rates of 15.3% (95% CI ¼ 2.3-34.9%). Procedure-related morbidity was 31.0% (95 CI ¼ 12.3-53.3%) and peri-operative mortality was 7.1% (95% CI ¼ 0-20.5%). Long-term morbidity and mortality rates were 8.5% (95% CI ¼ 0-25.6%) and 7.1% (95% CI ¼ 0-20.5%), respectively. With endovascular treatment of unruptured aneurysms, complete occlusion was seen in 75.7% (95% CI ¼ 45.4-97.1%) with recurrence rates of 12.4% (95% CI ¼ 1.4-29.8%). Peri-operative mortality was 3.7% (95% CI ¼ 0-10.6%). Procedure-related mortality was 3.7% (95% CI ¼ 0-10.6%). Long-term morbidity and mortality rates were 5.1% (95% CI ¼ 0.2-14.4%) and 3.7% (95% CI ¼ 0-10.6%), respectively. Interestingly, there were higher rates of aneurysm rupture (7.1% vs. 3.7%) and peri-operative stroke (8.5% vs. 4.4%) in the surgical arm compared with the endovascular arm; however, overall similar rates of favourable neurological outcome were seen in both groups (91.5% in the surgical cohort and 93.3% in the endovascular cohort). In the ruptured PICA aneurysms treated surgically, the occlusion rate was 97.1% (95% CI ¼ 94.5-99.0%) with recurrence rates of 1.4% (95% CI ¼ 0.3-3.3%). Procedure-related morbidity was 10.8% (95% CI ¼ 4.7-19.0%) and peri-operative mortality was 9.3% (95% CI ¼ 5.2-14.5%). Long-term morbidity and mortality rates were 14.4% (95% CI ¼ 8.7-21.2%) and 9.8% (95% CI ¼ 5.8-14.8%), respectively. With endovascular treatment of ruptured aneurysms, complete occlusion was seen in 84.3% (95% CI ¼ 73.8-92.6%) with recurrence rates of 6.9% (95% CI ¼ 3.6-10.9%). Peri-operative mortality was 15.1% (95% CI ¼ 9.3-22.0%). Procedure-related mortality was 3.5% (95% CI ¼ 1.0-7.3%). Long-term morbidity and mortality rates were 15.1% (95% CI ¼ 10.5-20.2%) and 17.1% (95% CI ¼ 11.5-23.7%), respectively. The authors note that both treatment modalities were associated with high rates of acute hydrocephalus, which was seen more frequently in the surgical cohort than the endovascular cohort. Overall, the authors suggest that both treatment modalities are safe and effective but surgery results in a higher rate of angiographic occlusion. The authors also found a substantial difference in procedure-related morbidity favouring the distal PICA location (5.2 vs. 10.6%). In particular, in the surgical group with distal PICA aneurysm, the morbidity was 5.5% compared to 11.2% for those with proximal aneurysms. Similarly, in the endovascular group harboring distal PICA aneurysms, procedure-related morbidity was 7.35% compared to 12.7% for proximal aneurysms. This is likely related to a variety of difference factors including the presence of perforators on the proximal PICA. This, as mentioned earlier, is of concern when using an FDS; however, to the best of our knowledge, there are currently no publications that mention perforator occlusion after placement of an FDS in the PICA.
Overall, we feel that proximal aneurysms may be better suited to endovascular treatment with flow diversion; however, this is dependent upon several factors, including the size of the PICA, the microcatheter required to deploy the FDS, the anatomical disposition and presence of perforators, and the ability to safely access the PICA. Although a variety of techniques, such as the 'looping' technique, can be used to access the PICA when the take-off of this vessel from the VA is particularly acute, it has been reported that it may be more advisable to opt for a surgical treatment when endovascular access will prove challenging. We also feel that flow diversion represents a viable treatment option for non-saccular and dissecting aneurysms of the PICA, particularly if the proximal PICA is involved, whereas vessel sacrifice should be considered for similar lesions located more distally on the vessel.
As with the use of flow diverters elsewhere, coverage of perforators is a concern. Although there is considerable evidence now to suggest that side branches remain patent when there is no competing flow, 21, 22, [34] [35] [36] this is of no doubt a concern. This is especially true when the perforators supply very eloquent territories, such as those arising from the PICA. The potential origin of the perforating arteries and the lateral spinal artery is related to the origin of the vertebral artery itself. If the PICA emerges from the common trunk of the AICA-PICA coming from the basilar artery, it never gives off perforating arteries or a lateral spinal artery on the lateral surface of the brain stem but supplies blood to a part of the ipsilateral cerebellar hemisphere. If the PICA arises extradurally at C1, it never gives off perforating arteries for the lateral surface of the brain stem, but it gives pial branches for the posterior surface of the medullar oblongata and is always the origin of the lateral spinal artery. If the PICA emerges in the intradural vertebral artery, it is the source of the perforating arteries for the lateral surface of the brain stem and of the blood supply of the ipsilateral cerebellum. 37 The size of the PICA is also of concern when considering the use of an FDS as a treatment option; however, flow diverters have been implanted successfully in small vessels previously. Puri and colleagues 38 presented their results of aneurysms, arising from small caliber arteries with a mean diameter of 1.9 mm (range 1.5-2.3 mm). They identified seven patients (six female) with a mean age of 65 years. The mean aneurysm size was 3.9 mm (range 1-12 mm). Four of the aneurysms were incidental, with the remaining aneurysms having previously been treated acutely with coils following rupture of the aneurysm. The admission mRS was 0 in six of the patients and 5 in one patient. In all cases, a 2.5 mm PED was deployed. Complete aneurysm occlusion was seen in all six cases with follow-up angiography (86%) and the mRS remained unchanged for all patients. All of these cases involved arteries of the anterior circulation and other groups have published their results on the use of FDSs in smaller caliber vessels, such as the anterior cerebral artery, [39] [40] [41] [42] with reasonable results. Dabus et al., 39 who did report the diameter of the vessels (range 1-2.6 mm, mean 1.8 mm) reported that 11 of 16 aneurysms were completed occluded at follow-up (68.8%) at a mean of 10 months post-intervention. A single patient in this cohort died secondary to a large remote haemorrhage. Another patient suffered from a caudate infarction; however, she rapidly recovered to baseline neurology. Therefore, although there is limited evidence regarding the use of FDSs within the PICA there are reports in the literature on the use of these devices within similar caliber vessels. When considering the use of FDSs in small vessels, it is important to understand and consider the effects of oversizing on the FDS. Oversizing will result in lengthening of the device 19 and this may make it difficult to accurately predict the proximal landing zone of the FDS. Additionally, as the metal coverage varies as a parabolic function of the ratio between the vessel and the device, with the typical oversized mismatch resulting in reduced metal coverage, 19, 20 there may be an effect on the aneurysm occlusion. However, this may have the counter effect of limiting the coverage of perforators and hence potential perforator occlusion. These things must be considered when deciding upon an appropriate course of treatment and, in general, we would not advocate the use of FDSs in vessels smaller than 1.5-1.6 mm.
Our study is limited by its retrospective nature and small number of cases. In addition, as several different FDSs were used, it is difficult to deduce whether the results will be similar amongst the different types of FDS. Furthermore, as only one of our cases was treated in the acute setting after SAH, it is difficult to accurately determine the safety profile of this treatment in the acute setting.
Conclusion
We present our series of PICA aneurysms, both ruptured and unruptured, treated with the implantation of an FDS solely within the PICA. Whilst we believe that standard surgical and endovascular treatment options should remain the mainstay of treatment for the majority of these aneurysms, the use of FDSs to treat PICA aneurysms may be a feasible treatment option in select cases and may prove particularly useful for the treatment of proximal PICA aneurysms.
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